You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-Xa activity

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vasopressors on Anti-Xa Activity in Critically Ill Patients

Recruiting
  • Critical Illness
  • Thrombosis
  • Serum anti-Xa activity
  • Gdańsk, Poland
    Medical University of Gdańsk - Departament of Anesthesiology and
Sep 20, 2023

LR-ACT and Anti Xa Activity During Endovascular Surgery

Not yet recruiting
  • Aortic Diseases
  • +2 more
  • Anti Xa activity measurement.
  • Bron, France
    Service de chirurgie vasculaire (U50) Hôpital Louis Pradel - HCL
Sep 21, 2022

Nephrotic Syndrome Trial in Warsaw (Enoxaparin)

Terminated
  • Nephrotic Syndrome
  • Warsaw, Masovian District, Poland
    Military Institute of Medicine
Jan 26, 2023

Anticoagulants and Bleeding Disorders, Surgery, Regional Anesthesia Morbidity Trial in Winston-Salem (Enoxaparin)

Terminated
  • Anticoagulants and Bleeding Disorders
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Baptist Medical Center
Dec 4, 2022

Anti-Xa Activity Trial in Vancouver (apixaban)

Terminated
Has Results
  • Anti-Xa Activity
  • Vancouver, British Columbia, Canada
    Vancouver General Hospital
Jul 28, 2021

Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and

Unknown status
  • Anticoagulation
  • +2 more
  • Estimated anticoagulant level (conversion factor x anti-Xa activity)
  • (no location specified)
Nov 30, 2020

Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19

Completed
  • Critical Illness
  • +2 more
  • blood sampling
  • Arnhem, Netherlands
    Monique de Maat
Jun 28, 2023

Dose Regimen of Intravenous Unfractionated Heparin and Low

Active, not recruiting
  • COVID-19
  • +3 more
  • Gent, Belgium
    Ghent University Hospital
Oct 24, 2022

Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving

Not yet recruiting
  • Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis
  • Assessment the activity of anti-Xa factor.
  • Gdańsk, Pomorskie, Poland
    Medical University of Gdansk - Departament of Anesthesiology and
Dec 15, 2020

Acute Coronary Syndrome Trial in Monastir (LOVENOX, ENOXAMED)

Completed
  • Acute Coronary Syndrome
  • Monastir, Tunisia
    Emergency Department of University Hospital of Monastir
Jul 20, 2020

Specific PoC Testing of Coagulation in Patients Treated With

Recruiting
  • Anticoagulation With NOAC
  • anti-Xa activity point-of-care testing (aXa-POCT)
  • ecarin clotting time point-of-care testing (ECT-POCT)
  • Tuebingen, Germany
    University Hospital Tuebingen
Dec 14, 2020

Venous Thromboembolism Trial (Peak value anti-Xa, Trough value anti-Xa, Control Group)

Not yet recruiting
  • Venous Thromboembolism
  • Peak value anti-Xa
  • +2 more
  • (no location specified)
May 15, 2022

Dose Adjustment of Enoxaparin in ICU Patients Trial in Kfar Saba (Dose adjustment of Enoxaparin in patients with sub-therapuetic

Completed
  • Dose Adjustment of Enoxaparin in ICU Patients
  • Dose adjustment of Enoxaparin in patients with sub-therapuetic (prophylactic) levels of factor 10a
  • Kfar Saba, Israel
    Meir Medical Center
Jan 23, 2022

Pediatric Kidney Transplant Recipients Trial in Paris (Bayesian based dose adjustment of enoxaparin, Usual dose adjustment of

Not yet recruiting
  • Pediatric Kidney Transplant Recipients
  • Bayesian based dose adjustment of enoxaparin
  • Usual dose adjustment of enoxaparin
  • Paris, Ile-de-France, France
    Hôpital Necker - Enfants malades
Jan 23, 2023

'CTR' Ratio With Standard Haemostasis Parameters in Follow-up of

Recruiting
  • Venous Thromboembolic Disease
    • Saint-Mandé, France
      HIA Bégin
    Aug 7, 2023

    Is Anti-Factor Xa Associated With Outcome in Critical COVID-19

    Completed
    • Covid19
    • +2 more
    • The effect of LMWH
    • Monitoring frequency of aFXa-levels
    • Stockholm, Sweden
      Södersjukhuset
    Feb 24, 2022

    Dextran Sulphate on Anti-Xa Activities Measured

    Completed
    • Unfractionated Heparin Treatment
    • measurement of anti-Xa activities
    • Bordeaux, France
    • +7 more
    Feb 8, 2021

    Advanced Solid Tumors Trial (RO7589831)

    Not yet recruiting
    • Advanced Solid Tumors
    • (no location specified)
    Aug 16, 2023

    Traumatic Injury, Venous Thromboembolism Trial in Cincinnati (Enoxaparin 40 mg q12h, Enoxaparin 30 mg q8h)

    Completed
    Has Results
    • Traumatic Injury
    • Venous Thromboembolism
    • Enoxaparin 40 mg q12h
    • Enoxaparin 30 mg q8h
    • Cincinnati, Ohio
      University of Cincinnati Medical Center
    Oct 22, 2021

    Solid Tumor, Adult, Solid Tumor, Gastric Cancer Trial in Seongnam, Seoul (PB101)

    Recruiting
    • Solid Tumor, Adult
    • +5 more
    • Seongnam, Korea, Republic of
    • +2 more
    Oct 11, 2023

    Advanced Solid Tumor Trial (HBM1020)

    Not yet recruiting
    • Advanced Solid Tumor
    • (no location specified)
    Apr 10, 2023

    Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Advanced Malignant Neoplasm
    • +2 more
    • Laboratory Biomarker Analysis
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 13, 2022

    HIV-1, Human Immunodeficiency Virus 1, Immunodeficiency Virus Type 1, Human Trial (MK-8510)

    Not yet recruiting
    • HIV-1
    • +3 more
    • (no location specified)
    Jan 17, 2023

    Metastatic Castration-resistant Prostate Cancer Trial (HP518 - Dose Escalation, HP518 -Dose Expansion)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • HP518 - Dose Escalation
    • HP518 -Dose Expansion
    • (no location specified)
    Dec 1, 2023

    Lung Diseases, Interstitial Trial in Tampa (Actigraph CP Insight Watch)

    Not yet recruiting
    • Lung Diseases, Interstitial
    • Actigraph CP Insight Watch
    • Tampa, Florida
      University of South Florida/ Tampa General Hospital
    May 10, 2023